Complementary and Alternative Care for RSV
Clinicians should inquire about complementary and alternative medicine (CAM) use in children with RSV, but no specific CAM therapies are recommended for treatment or prevention of RSV bronchiolitis. 1
Evidence-Based Guidance on CAM for RSV
The American Academy of Pediatrics 2006 bronchiolitis guideline explicitly addresses CAM by stating that clinicians should inquire about CAM use (option-level recommendation) 1. However, this is purely an assessment recommendation—there is no endorsement of any specific CAM modalities for RSV treatment or prevention.
What This Means in Practice
- No CAM therapies have demonstrated efficacy for RSV bronchiolitis in clinical trials
- The guideline's mention of CAM is limited to awareness and documentation, not therapeutic recommendation
- The focus remains entirely on evidence-based supportive care and prevention strategies
What Actually Works: Evidence-Based Prevention and Management
Instead of CAM approaches, the guidelines strongly emphasize proven preventive measures:
Primary Prevention Strategies (These are the "complementary" measures that actually work):
Hand hygiene is the single most important intervention:
- Hand decontamination before and after patient contact is a strong recommendation 1
- Alcohol-based rubs are preferred over antimicrobial soap 1
- Education of family members on hand sanitation is essential 1
Environmental and lifestyle modifications:
- Infants must not be exposed to passive smoking (strong recommendation) 1, 2
- Breastfeeding is recommended to decrease risk of lower respiratory tract disease 1, 2
- Keep high-risk infants away from crowds and uncontrolled exposure situations 2
- Restrict participation in group child care during RSV season for high-risk infants 2
Infection control measures:
- Avoid contact with individuals who have respiratory infections 2
- Ensure all family contacts receive age-appropriate immunizations, including influenza vaccine 2
Medical Prophylaxis for High-Risk Infants
For eligible high-risk children, palivizumab (passive immunoprophylaxis) is the only proven preventive intervention:
- Reduces RSV hospitalization by 39-82% in high-risk groups 2
- Reserved for specific populations: premature infants, chronic lung disease, hemodynamically significant congenital heart disease 1, 3
Critical Pitfall to Avoid
Do not recommend unproven CAM therapies as alternatives to evidence-based supportive care. The treatment of RSV remains exclusively supportive, with specific interventions like:
- Supplemental oxygen for SpO2 <90% 1
- Hydration assessment and fluid support 1
- Monitoring respiratory status 1
The guideline's inclusion of CAM inquiry is for safety monitoring and documentation purposes only—to ensure families aren't using potentially harmful alternatives or delaying appropriate medical care, not because any CAM modalities are recommended.